BRIC INVEST offers 30 pct presale bonus for Dutch eHealth care provider Aimedis

KUALA LUMPUR, June 5 (Bernama) -- BRIC INVEST -- the Czech investment house -- offers 30 per cent presale bonus plus a five per cent welcome premium for Aimedis’ AIM -- the cryptocurrency to be used for all kinds of services within Aimedis platform to the public.


Aimedis is a Dutch eHealth-provider and creator of a blockchain and AI-based platform that allow patients and institutions to safely store and share health information such as diagnoses, x-rays, blood screens and many more.


It also enables patients and institutions to perform video consultations or to get prescriptions for drugs online, a statement said.


Aimedis strives to raise US$36 million (RM 141,12 million) to finance further development by offering 300 million tokens with a nominal value of US$0.12 (RM 0.47) per token. (1 US$ = RM 3.92) “The AIM-ICO will provide the funds we need to finance further development of the platform and its functionalities that are planned for the next quarters and to set up international teams as well,” said chief executive officer of Aimedis, Dr. Michael J. Kaldasch.


BRIC INVEST is a subsidiary of BRIC HOLDING SE that holds strategic interests in the field of E-Health, energy and real estate. More information at https://www.bric-holding.com.


--BERNAMA





HealthEdge


EXCLUSIVE

Vivantis Technologies Elevates COVID-19 Testing Capacity In Malaysia

By Nadia Jumri

KUALA LUMPUR (Bernama) – The world has been battling COVID-19 for close to a year now, with more than 200 countries and territories affected by the pandemic.

In Malaysia, the third wave of infections led to total case numbers spiking to over 75,000. Globally, the virus has infected more than 68 million people and caused over 1.5 million fatalities.

Due to the virus’ highly virulent nature, producing COVID-19 test kits has become a top priority for certain biotechnology companies focusing on research and development (R&D) in Malaysia.

read more ››

IN FOCUS

Pandangan rakyat Malaysia tentang peningkatan sasaran pemberian vaksin COVID-19 kepada 70 peratus.


UMSC: Pain Management

In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1